Unum Therapeutics
UMRX
#9439
Rank
โ‚ฌ63.43 M
Marketcap
2,04ย โ‚ฌ
Share price
0.43%
Change (1 day)
N/A
Change (1 year)

Revenue for Unum Therapeutics (UMRX)

Revenue in 2020 (TTM): โ‚ฌ20.75 Million

According to Unum Therapeutics's latest financial reports the company's current revenue is โ‚ฌ20.06 Million. In 2019 the company made a revenue of โ‚ฌ19.49 Million an increase over the revenue in the year 2018 that were of โ‚ฌ8.43 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Unum Therapeutics from 2017 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚ฌ20.75 M6.51%
2019โ‚ฌ19.49 M131.14%
2018โ‚ฌ8.43 M16.44%
2017โ‚ฌ7.24 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Omeros Corporation
OMER
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA